The use of peripheral CD3 + γδ + Vδ2 + T lymphocyte cells in combination with the ALBI score to predict immunotherapy response in patients with advanced hepatocellular carcinoma: a retrospective study.

Shuhan Zhang Luyang Li Cheng-Li Liu Meng Pu Yingbo Ma Tao Zhang Jiaqi Chai Haoming Li Jun Yang Meishan Chen Ling-Hong Kong Tian Xia

Published in: Journal of cancer research and clinical oncology (2024)

T lymphocytes in the peripheral blood of patients with advanced HCC are helpful for predicting the patients' responses to ICIs, helping to screen patients who may clinically benefit from immunotherapy. RETROSPECTIVELY REGISTERED: number: ChiCTR2400080409, date of registration: 2024-01-29.

Keyphrases

peripheral blood
end stage renal disease
induced apoptosis
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
high throughput
oxidative stress
patient reported outcomes
signaling pathway